Nav: Home

Amoebas reveals how human airway cells rally against cigarette smoke damage

December 14, 2015

SAN DIEGO, CA--Everyone knows that cigarette smoke is bad for your lungs. Just how bad can be seen in chronic obstructive pulmonary disease (COPD), the third leading cause of death in the U.S. Air pollution and other airborne irritants can be a factor but the National Institutes of Health is unequivocal--cigarette smoking is the leading cause of COPD. Despite its prevalence and ongoing research into COPD, there is no cure, current treatments are largely palliative, and new treatment targets are scarce. Now Corrine Kliment and colleagues in Doug Robinson's lab at Johns Hopkins University have found two new targets in a surprising place--amoebas. The researchers will present at ASCB 2015 in San Diego on Monday, December 14.

The social amoeba, Dictyostelium discoideum (or "Dicty"), is a great model for human COPD, the Hopkins researchers say, because it reacts so strongly and predictably to cigarette smoke or its laboratory form, cigarette smoke extract (CSE). The CSE damages Dicty's cytoskeleton and metabolism, bedrock cell processes that it shares with its very distant evolutionary cousins, humans. CSE causes Dicty to slow its growth dramatically and in a concentration-dependent manner. That gave the researchers a clear read-out when screening for Dicty genes that seemed to offer a protective effect against CSE. Utilizing a cDNA library to screen over 30,000 transformants led them to two genes, one involved in changes in the cell's skeleton, Aip1, the other, AncA, in the mitochondria, the cell's energy factories. The ancA gene has prominent paralogs in humans, the ANT genes. Reintroducing the two genes confirmed protection in Dicty against CSE. Turning to a lab culture of human bronchial epithelial cells (HBEKTs) that line the lung's airways, the researchers saw that both the ANT gene family and Aip1 protect the cells against cell death from CSE. Insulted by CSE, the HBEKTs tried to fight back by raising the ANT1 gene output. By turning up the expression of ANT2 genes, the researchers ramped up the counterattack against CSE, resulting in visibly strengthened HBEKT cells.

The humble amoeba, Dicty, has opened a new path, say Kliment et al., to understand the mechanism by which human airway cells protect themselves against cigarette smoke. New pathways, new targets, and new treatments are all badly needed against this so far intractable killer, COPD.
-end-
Contact Author: Corrine Kliment
cklimen1@jhmi.edu

At ASCB 2015

Author presents:
Poster Session: Defining Therapeutic Targers & New Therapeutics 2
Monday, December 14
1:30-3:00 pm
P1602
Board Number: B1682
ASCB Learning Center

Cytoskeletal and Mitochondrial Genes as New Targets in the Protection of Airway Epithelial Cells Against Cigarette Smoke
C.R. Kliment1,2, Y. Lu3, S.M. Claypool3, R. Sidhaye1, D.N. Robinson2
1Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, 2Cell Biology, Johns Hopkins University, Baltimore, MD, 3Physiology, Johns Hopkins University, Baltimore, MD

Figure caption
ANT2 maintains normal cell morphology of human bronchial epithelial cells after 40% cigarette smoke extract after 24 hours. @ASCBiology #ASCB15

American Society for Cell Biology

Related Copd Articles:

New hope for COPD patients possible with in-home device
In a new paper published Feb. 4 in JAMA, Mayo Clinic researchers describe the benefits of in-home noninvasive ventilation therapy, which includes a type referred to as bilevel positive airway pressure, or BiPAP -- for many patients with chronic obstructive pulmonary disease (COPD).
COPD appears to cause more severe symptoms in women
Women who develop COPD report smoking fewer cigarettes than men; and yet, women experience greater breathing impairments, are subjected to more acute exacerbations of symptoms and report lower quality of life than men with the disease, according to research presented at ATS 2019.
African-Americans with COPD appear less likely to use pulmonary rehab
African-American patients with chronic obstructive pulmonary disease, or COPD, are less likely to participate in pulmonary rehabilitation programs than white patients, even when there are programs nearby.
COPD and type 2 diabetes
COPD and type 2 diabetes are two highly prevalent global health conditions associated with high mortality and morbidity.
Number of nonsmokers with COPD on the rise
The global burden of COPD is high, and prevalence of nonsmokers with COPD has been increasing.
Flu vaccination keeps COPD patients out of the hospital
A new study published in the January issue of CHEST® establishes that patients with chronic obstructive pulmonary disease (COPD) face heightened risks of death, critical illness, and hospitalization if they develop the flu and demonstrates the beneficial effects of influenza vaccination.
Kidney disease biomarker may also be a marker for COPD
A commonly used biomarker of kidney disease may also indicate lung problems, particularly COPD, or chronic obstructive pulmonary disease, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
COPD-associated inflammation halted in model experiment
Chronic obstructive pulmonary disease, or COPD for short, is believed to be the third most common cause of death worldwide.
Study: Almost 100 million adults have COPD in China
Chronic obstructive pulmonary disease (COPD) is widespread in China with 8.6 percent of the country's adult population -- almost 100 million people -- suffering from the chronic lung disease, according to a new Tulane University study published in The Lancet.
Effective rehabilitation in COPD
By 2020, COPD will be the third most common cause of morbidity and mortality worldwide.
More COPD News and COPD Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Uncharted
There's so much we've yet to explore–from outer space to the deep ocean to our own brains. This hour, Manoush goes on a journey through those uncharted places, led by TED Science Curator David Biello.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 1: Numbers
In a recent Radiolab group huddle, with coronavirus unraveling around us, the team found themselves grappling with all the numbers connected to COVID-19. Our new found 6 foot bubbles of personal space. Three percent mortality rate (or 1, or 2, or 4). 7,000 cases (now, much much more). So in the wake of that meeting, we reflect on the onslaught of numbers - what they reveal, and what they hide.  Support Radiolab today at Radiolab.org/donate.